CHOLADDA CURRY

Concepts (227)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Large B-Cell, Diffuse
4
2024
143
1.610
Why?
Lymphoma, T-Cell
7
2021
65
1.530
Why?
Anemia, Aplastic
2
2025
59
1.470
Why?
Translocation, Genetic
4
2024
355
1.320
Why?
Epstein-Barr Virus Infections
3
2022
293
1.310
Why?
Myelodysplastic Syndromes
3
2017
138
0.980
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
2018
128
0.970
Why?
Lupus Erythematosus, Systemic
2
2025
188
0.960
Why?
Ethosuximide
1
2025
13
0.960
Why?
Burkitt Lymphoma
2
2024
144
0.890
Why?
Lymphoma, Large-Cell, Anaplastic
2
2022
46
0.880
Why?
Proto-Oncogene Proteins c-bcl-2
1
2024
172
0.850
Why?
Biomarkers, Tumor
6
2024
1475
0.830
Why?
Herpesvirus 4, Human
3
2022
676
0.820
Why?
Anticonvulsants
1
2025
375
0.770
Why?
Anemia, Iron-Deficiency
1
2023
133
0.730
Why?
T-Lymphocytes
2
2019
1708
0.680
Why?
Lymphoma, B-Cell
1
2021
142
0.670
Why?
Anemia
1
2023
340
0.660
Why?
Flow Cytometry
3
2017
796
0.650
Why?
Tertiary Healthcare
1
2019
21
0.640
Why?
Central Nervous System Neoplasms
1
2021
196
0.620
Why?
Hodgkin Disease
1
2021
294
0.620
Why?
Lymphocyte Transfusion
1
2018
57
0.600
Why?
Leukopenia
2
2023
44
0.590
Why?
Lymphoproliferative Disorders
1
2019
225
0.570
Why?
Hemoglobinuria, Paroxysmal
1
2017
20
0.560
Why?
Oncogene Proteins, Fusion
4
2022
208
0.500
Why?
Chromosomes, Human, Pair 20
1
2015
32
0.480
Why?
Chromosomes, Human, Pair 10
1
2015
64
0.470
Why?
Receptors, Antigen, T-Cell
1
2018
481
0.470
Why?
Philadelphia Chromosome
1
2014
41
0.460
Why?
Fusion Proteins, bcr-abl
1
2014
40
0.460
Why?
Lymphoma, B-Cell, Marginal Zone
1
2015
61
0.460
Why?
Interleukin-2 Receptor alpha Subunit
1
2014
44
0.460
Why?
Protein-Tyrosine Kinases
4
2017
209
0.450
Why?
Panniculitis
1
2013
19
0.430
Why?
Receptor Protein-Tyrosine Kinases
3
2022
127
0.420
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2013
66
0.410
Why?
Adolescent
14
2025
19240
0.410
Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
2013
85
0.390
Why?
Myeloproliferative Disorders
1
2013
87
0.390
Why?
In Situ Hybridization, Fluorescence
3
2015
762
0.390
Why?
Chromosome Aberrations
1
2015
617
0.380
Why?
Leukemia, Megakaryoblastic, Acute
2
2022
20
0.380
Why?
Immunologic Deficiency Syndromes
1
2012
205
0.340
Why?
Monocytes
1
2012
351
0.330
Why?
Child
12
2024
24349
0.320
Why?
Humans
34
2025
124161
0.320
Why?
Sarcoma, Clear Cell
1
2008
20
0.290
Why?
Leukemia, Myeloid, Acute
3
2024
539
0.290
Why?
Gene Rearrangement
2
2014
319
0.280
Why?
Bone Marrow
3
2021
324
0.270
Why?
Soft Tissue Neoplasms
1
2008
121
0.260
Why?
Tertiary Care Centers
2
2023
236
0.250
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2008
1282
0.240
Why?
Diagnosis, Differential
5
2024
1878
0.240
Why?
Female
12
2025
66270
0.240
Why?
Biopsy, Fine-Needle
2
2017
116
0.230
Why?
Primary Myelofibrosis
2
2023
51
0.230
Why?
Transcription Factors
3
2022
2582
0.230
Why?
Lymph Nodes
2
2019
381
0.230
Why?
DNA (Cytosine-5-)-Methyltransferases
2
2016
136
0.220
Why?
Chromosomes, Human, Pair 8
1
2024
78
0.220
Why?
Reticulocytes
1
2023
42
0.220
Why?
Chromosomes, Human, Pair 14
1
2024
100
0.220
Why?
Male
15
2023
60995
0.210
Why?
Retrospective Studies
6
2023
16280
0.200
Why?
Hemoglobins
1
2023
303
0.200
Why?
ROC Curve
1
2023
567
0.190
Why?
Drug Eruptions
1
2021
32
0.190
Why?
Cryptococcosis
1
2021
42
0.190
Why?
B7-H1 Antigen
1
2022
110
0.190
Why?
Ribs
1
2021
42
0.190
Why?
Programmed Cell Death 1 Receptor
1
2022
120
0.180
Why?
Adenine
1
2021
101
0.180
Why?
Ligands
1
2022
531
0.180
Why?
Child, Preschool
6
2019
13993
0.170
Why?
Autoimmune Diseases
1
2023
251
0.170
Why?
Down-Regulation
4
2017
697
0.170
Why?
Mediastinal Neoplasms
1
2020
40
0.170
Why?
Neoplasm Staging
2
2015
1233
0.170
Why?
Piperidines
1
2021
204
0.170
Why?
Central Nervous System
1
2021
251
0.170
Why?
Sarcoma, Myeloid
1
2019
12
0.170
Why?
Neoplasms, Germ Cell and Embryonal
1
2020
87
0.170
Why?
Disease Susceptibility
1
2021
298
0.160
Why?
Proto-Oncogene Proteins p21(ras)
1
2020
157
0.160
Why?
Testicular Neoplasms
1
2020
132
0.160
Why?
Lymphohistiocytosis, Hemophagocytic
1
2021
145
0.160
Why?
Predictive Value of Tests
2
2015
2142
0.160
Why?
DNA Methylation
2
2016
1002
0.160
Why?
Prognosis
3
2019
4608
0.160
Why?
Osteomyelitis
1
2021
203
0.160
Why?
Cell Proliferation
4
2018
2284
0.150
Why?
Biopsy
3
2021
1237
0.150
Why?
Neoplasm Recurrence, Local
1
2024
1136
0.140
Why?
Lung Transplantation
1
2021
320
0.140
Why?
Up-Regulation
3
2015
862
0.140
Why?
Biopsy, Large-Core Needle
1
2017
30
0.140
Why?
Image-Guided Biopsy
1
2017
37
0.140
Why?
fms-Like Tyrosine Kinase 3
1
2016
23
0.130
Why?
Megakaryocytes
1
2016
42
0.130
Why?
Syndrome
1
2018
1119
0.120
Why?
Apoptosis
1
2022
1781
0.120
Why?
MicroRNAs
2
2013
835
0.120
Why?
Protein Kinases
1
2017
332
0.120
Why?
Sumoylation
1
2015
35
0.120
Why?
Receptors, Somatomedin
1
2015
25
0.120
Why?
Monosomy
1
2015
24
0.120
Why?
Promoter Regions, Genetic
2
2015
1328
0.110
Why?
Kruppel-Like Transcription Factors
1
2015
108
0.110
Why?
Thrombocytopenia
1
2016
221
0.110
Why?
Immunophenotyping
1
2015
329
0.110
Why?
Immunohistochemistry
2
2015
1688
0.110
Why?
DNA, Neoplasm
1
2015
301
0.110
Why?
Leukemia, Promyelocytic, Acute
1
2014
24
0.110
Why?
Cytokines
2
2021
1289
0.110
Why?
Lymphoma, T-Cell, Peripheral
1
2013
15
0.110
Why?
Solitary Pulmonary Nodule
1
2013
23
0.110
Why?
Genomics
1
2021
1492
0.110
Why?
Axilla
1
2013
38
0.110
Why?
Tomography, X-Ray Computed
1
2021
2089
0.110
Why?
Protein Processing, Post-Translational
1
2015
355
0.110
Why?
Lung Neoplasms
2
2013
1596
0.100
Why?
Leukemia
1
2016
369
0.100
Why?
Nitric Oxide Synthase Type II
1
2013
95
0.100
Why?
Fatal Outcome
1
2013
355
0.100
Why?
Sensitivity and Specificity
1
2017
2041
0.100
Why?
Liver
1
2019
1733
0.100
Why?
RNA, Neoplasm
1
2012
136
0.090
Why?
Hematologic Neoplasms
1
2015
284
0.090
Why?
Cell Transformation, Neoplastic
1
2015
616
0.090
Why?
Infant
4
2019
12465
0.090
Why?
Recurrence
1
2015
1421
0.090
Why?
STAT3 Transcription Factor
1
2013
221
0.090
Why?
Hematopoietic Stem Cells
1
2015
536
0.090
Why?
Prevalence
1
2017
2445
0.090
Why?
Follow-Up Studies
1
2019
5129
0.080
Why?
Genetic Predisposition to Disease
2
2021
3148
0.080
Why?
Cell Survival
3
2017
805
0.080
Why?
Carcinoma, Non-Small-Cell Lung
1
2012
333
0.080
Why?
RNA-Binding Protein EWS
1
2008
33
0.070
Why?
Calmodulin-Binding Proteins
1
2008
63
0.070
Why?
Age Factors
1
2014
2806
0.070
Why?
Cell Line, Tumor
4
2017
3328
0.070
Why?
Heart Transplantation
1
2013
853
0.070
Why?
Gene Expression Regulation, Neoplastic
4
2016
1891
0.070
Why?
Treatment Outcome
2
2015
12289
0.060
Why?
Protein Kinase Inhibitors
2
2021
529
0.060
Why?
Phenotype
1
2015
4249
0.060
Why?
Time Factors
1
2015
6283
0.060
Why?
Young Adult
2
2017
8988
0.060
Why?
RNA-Binding Proteins
1
2008
573
0.050
Why?
Mice
5
2021
17622
0.050
Why?
Neoplasms
1
2017
2765
0.050
Why?
Phosphorylation
2
2017
1615
0.050
Why?
Mutation
3
2021
5812
0.050
Why?
Perforin
1
2021
17
0.050
Why?
Middle Aged
3
2021
26589
0.050
Why?
Acute Disease
1
2024
1107
0.040
Why?
Cell Movement
2
2015
834
0.040
Why?
Algorithms
2
2021
1606
0.040
Why?
Cytogenetic Analysis
1
2020
79
0.040
Why?
T-Lymphocyte Subsets
1
2021
196
0.040
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
183
0.040
Why?
Animals
5
2021
34040
0.040
Why?
Clinical Decision-Making
1
2021
265
0.040
Why?
Antifungal Agents
1
2021
288
0.040
Why?
Killer Cells, Natural
1
2021
323
0.040
Why?
Signal Transduction
3
2017
4504
0.040
Why?
Repressor Proteins
1
2022
816
0.040
Why?
Disease Management
1
2021
518
0.040
Why?
Nerve Growth Factor
1
2017
21
0.040
Why?
Chondrosarcoma
1
2017
11
0.030
Why?
Rhabdoid Tumor
1
2017
48
0.030
Why?
Bone Marrow Examination
1
2016
14
0.030
Why?
Reticulin
1
2016
8
0.030
Why?
Integrin beta3
1
2016
26
0.030
Why?
Gene Knockout Techniques
1
2016
124
0.030
Why?
Mice, SCID
1
2017
566
0.030
Why?
Sarcoma, Ewing
1
2017
107
0.030
Why?
Jurkat Cells
1
2015
78
0.030
Why?
Neoplasms, Experimental
1
2016
209
0.030
Why?
3T3 Cells
1
2015
121
0.030
Why?
Protein Stability
1
2015
162
0.030
Why?
RNA, Small Interfering
1
2017
660
0.030
Why?
Bone and Bones
1
2017
265
0.030
Why?
Receptor, IGF Type 1
1
2015
93
0.030
Why?
Enhancer Elements, Genetic
1
2016
294
0.030
Why?
Aged
3
2021
19533
0.030
Why?
Xenograft Model Antitumor Assays
1
2017
882
0.030
Why?
Osteosarcoma
1
2017
252
0.030
Why?
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor
1
2013
5
0.030
Why?
Leukocytosis
1
2014
46
0.030
Why?
Disseminated Intravascular Coagulation
1
2014
67
0.030
Why?
Survival Analysis
1
2017
1491
0.030
Why?
Karyotyping
1
2014
328
0.030
Why?
Imines
1
2013
9
0.030
Why?
Protein Binding
1
2017
1736
0.030
Why?
Chromosomes, Human, Pair 15
1
2014
160
0.030
Why?
Gene Expression Regulation
1
2021
2521
0.030
Why?
Tyrosine
1
2013
150
0.030
Why?
Pneumonectomy
1
2013
130
0.020
Why?
Cohort Studies
1
2021
4780
0.020
Why?
Neprilysin
1
2012
19
0.020
Why?
Cell Adhesion
1
2013
324
0.020
Why?
Biomarkers
1
2021
3049
0.020
Why?
Chemotaxis
1
2012
55
0.020
Why?
Positron-Emission Tomography
1
2013
297
0.020
Why?
Chromosomes, Human, Pair 17
1
2014
369
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2014
503
0.020
Why?
Epigenesis, Genetic
1
2016
674
0.020
Why?
Gene Expression Regulation, Enzymologic
1
2012
256
0.020
Why?
Sequence Alignment
1
2012
621
0.020
Why?
Reproducibility of Results
1
2017
2862
0.020
Why?
Tumor Suppressor Proteins
1
2013
464
0.020
Why?
Nitric Oxide
1
2013
444
0.020
Why?
Transfection
1
2012
1062
0.020
Why?
Cell Line
1
2015
2745
0.020
Why?
Neoplastic Stem Cells
1
2012
295
0.020
Why?
Binding Sites
1
2012
1293
0.020
Why?
RNA, Messenger
1
2015
2814
0.020
Why?
Pediatrics
1
2017
1158
0.020
Why?
Base Sequence
1
2012
3089
0.020
Why?
Mice, Knockout
1
2015
3726
0.020
Why?
Adult
1
2023
29340
0.010
Why?
CURRY's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (227)
Explore
_
Co-Authors (52)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_